Malaysian Glove Stocks Rebound: Fundamental Recovery or Short-Term Speculation?

Malaysia Daily Update · Glove Counters Published 14 May 2026 After-close data
Quick answer

Is this glove stock rally a fundamental recovery or short-term speculation?

The recent rise in glove stocks shows signs of improving fundamentals, but it is also mixed with short-term themes and valuation expectations. It is better viewed through a “recovery confirmation” lens than by chasing the price on the pandemic theme alone.

01 · Background

Why glove stocks are back in focus

Malaysian glove stocks have recently drawn renewed market attention. Top Glove, Hartalega, Kossan, Supermax and other glove counters have seen clear buying interest, mainly for three reasons: a recovery in average selling price (ASP), market expectations of an earnings recovery, and hantavirus-related news fuelling short-term demand speculation. The Edge reported that glove stocks performed strongly on 11 May, with Top Glove up about 13%, Hartalega and Supermax each up about 11%, and Kossan up about 7%.

02 · Industry

Not just a “pandemic theme”: industry supply and demand are starting to improve

This rally is not entirely a return of the “pandemic theme”. The real point is that industry supply and demand are starting to improve. Over the past few years, the glove industry faced overcapacity, falling ASP, inventory digestion and low-price competition from Chinese manufacturers, which put many companies under heavy earnings pressure. The market is looking at glove stocks again because ASP is showing signs of recovery, plant utilisation is improving, and, after the US raised tariffs on Chinese medical gloves, Malaysian glove makers have a chance to improve their export competitiveness.

03 · ASP

A higher ASP does not necessarily mean a strong demand recovery

Investors should be clear on one point: a higher ASP does not necessarily mean a strong demand recovery. UOBKH Research noted that glove makers’ ASP has recently risen to about US$26 to US$28 per 1,000 pieces, but these price increases look more like cost pass-through and do not necessarily mean the industry has entered a genuine demand-led upcycle. In other words, if raw material costs rise at the same time, a higher ASP will not necessarily translate fully into higher profit margins.

04 · Costs

Raw material costs are a key variable

Raw material costs are one of the biggest variables in this round of glove stock gains. Reuters reported that the situation in the Middle East affected the petrochemical feedstock supply chain, pushing synthetic rubber glove prices higher at one point, and some glove makers passed part of the raw material cost on to customers. But market analysts also caution that if such increases are driven mainly by costs rather than a substantial rise in demand, the sustainability of the share price gains needs to be watched carefully.

05 · Results

At company level: Hartalega’s recovery is not yet a full rebound

At company level, Hartalega’s latest results show that a recovery is under way, but it is not yet a full rebound.

Hartalega FY2026 Q4This quarterSame quarter last year
Net profitRM40.47 millionRM14.48 million
Quarterly revenueRM515.42 millionRM611.55 million

The decline in revenue was mainly due to a stronger ringgit and lower ASP. This result shows that improved cost efficiency can lift earnings, but sales volume and pricing power remain constraints.

06 · Logic

The market prices in expectations first, then waits for results to confirm

So the core logic behind the recent glove stock moves can be summarised this way: the market first trades the “earnings recovery expectation” and only then waits for results to confirm it. Glove stocks usually react early, when orders, ASP and utilisation rate begin to improve, because investors are buying the earnings improvement expected over the next one or two quarters, not the historical figures already reported. The Edge also noted that restocking and order pull-forward tend to show up before they appear in actual earnings.

07 · Valuation

Valuations are no longer cheap

According to The Edge, citing Bloomberg consensus, the forward PE of each company is as follows.

CompanyForward PE (Bloomberg consensus)
Top GloveAbout 45x
HartalegaAbout 30.2x
KossanAbout 21.8x
SupermaxStill expected to post a loss over the next 12 months

These valuations show that the market has already priced a good deal of the expected recovery into share prices.

08 · What to watch

What to watch next

Glove stocks are not off the table, but investors should not chase them just because they “have risen a lot”. A more professional approach is to first watch the following points.

  • Whether ASP keeps rising
  • Whether raw material costs are stable
  • Whether utilisation rate keeps improving
  • Whether orders reflect real demand rather than short-term restocking
  • Whether gross margin genuinely widens in the next quarterly results
09 · Summary

The takeaway in one sentence

The recent rise in glove stocks shows signs of improving fundamentals, but it is also mixed with short-term themes and valuation expectations; it is better viewed through a “recovery confirmation” lens than by chasing the price on the pandemic theme alone.

10 · Key terms

Terms in this article

11 · Sources

Sources

  1. The Edge: glove stock performance on 11 May, Bloomberg consensus forward PE, views on restocking and order pull-forward
  2. Reuters: impact of the Middle East situation on the petrochemical feedstock supply chain and synthetic rubber glove prices
  3. UOBKH Research: views on glove makers’ ASP and cost pass-through
  4. Bloomberg consensus (cited by The Edge): forward PE estimates
  5. Hartalega FY2026 Q4 results

Note: All information is for reference only and does not influence any buy or sell decision.

Disclaimer: Finworld provides market education and research tools only, and this is not investment advice. Market data is after-close data.

Similar Posts

Leave a Reply